Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHP640 for Bacterial Conjunctivitis
NCT03004924Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2017
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 13
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone + povidone-iodine in bacterial conjunctivitis (BC), sponsored by Takeda. Started Mar 2017; status: completed.
02
Drugs
dexamethasone + povidone-iodine
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT03004924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03004924.